Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-gamma

Th2 T cell immune-driven inflammation plays an important role in allergic asthma. We studied the effect of counterbalancing Th1 T cells in an asthma model in Brown Norway rats that favors Th2 responses. Rats received i.v. transfers of syngeneic allergen-specific Th1 or Th2 cells, 24 h before aerosol exposure to allergen, and were studied 18-24 h later. Adoptive transfer of OVA-specific Th2 cells, but not Th1 cells, and OVA, but not BSA exposure, induced bronchial hyperresponsiveness (BHR) to acetylcholine and eosinophilia in a cell number-dependent manner. Importantly, cotransfer of OVA-specific Th1 cells dose-dependently reversed BHR and bronchoalveolar lavage (BAL) eosinophilia, but not mucosal eosinophilia. OVA-specific Th1 cells transferred alone induced mucosal eosinophilia, but neither BHR nor BAL eosinophilia. Th1 suppression of BHR and BAL eosinophilia was allergen specific, since cotransfer of BSA-specific Th1 cells with the OVA-specific Th2 cells was not inhibitory when OVA aerosol alone was used, but was suppressive with OVA and BSA challenge. Furthermore, recipients of Th1 cells alone had increased gene expression for IFN-gamma in the lungs, while those receiving Th2 cells alone showed increased IL-4 mRNA. Importantly, induction of these Th2 cytokines was inhibited in recipients of combined Th1 and Th2 cells. Anti-IFN-gamma treatment attenuated the down-regulatory effect of Th1 cells. Allergen-specific Th1 cells down-regulate efferent Th2 cytokine-dependent BHR and BAL eosinophilia in an asthma model via mechanisms that depend on IFN-gamma. Therapy designed to control the efferent phase of established asthma by augmenting down-regulatory Th1 counterbalancing mechanisms should be effective.     

Ammonia removal from a waste air stream using a biotrickling filter packed with polyurethane foam through the SND process

This paper presents the results of a bench-scale biotrickling filter (BTF) on the removal of ammonia gas from a waste stream using a simultaneous nitrification/denitrification (SND) process. It was found that the developed BTF could completely remove 100 ppm ammonia from a waste stream, with an empty bed retention time of 60 s and 98.4% nitrogen removal through the SND process under the tested conditions. It was elucidated that both autotrophic and heterotrophic bacteria were involved in the nitrogen removal trough the SND process in the BTF. Additionally, the elimination capacity of total nitrogen by the BTF increased from 3.5 to 18.4 g N/m³ h with an inlet load of 20.6 g N/m³ h (73.6%). The findings of this study suggest that the BTF can be operated to attain complete ammonia removal through the SND process, thereby making the treatment of ammonia-laden gas streams both short and cost-effective.     

Facies features and paleoenvironmental reconstruction of the Early to Middle Devonian syn-rift volcano-sedimentary succession (Padeha Formation) in the Eastern-Alborz Mountains,NE Iran

The Padeha Formation in the Eastern-Alborz Mountains (northeast Iran) is an Early to Middle Devonian syn-rift succession. Siliciclastic rocks (conglomerates, sandstones, mudstones, and red paleosols) to non-marine carbonates (yellowish calcretes, dolocretes, stromatolites, and sandy bivalve packstone) associated with volcaniclastic rocks (basalts or andesites and tuffs) are present in this succession. Facies analysis led to the recognition of three facies associations that are deposited in three terrestrial environments (alluvial fan, distal fan, and palustrine/lacustrine). Its sedimentary fill pattern and association with mafic volcaniclastic rocks indicate that this formation is related to the initial phase of a rift basin (intracratonic rift). Paleosols of this formation are good indicators for recognition of paleoenvironmental factors (climatic changes from semi-arid to sub-humid with annual fluctuation, small and short gross-like vegetation cover, subaerial exposure, very shallow lake, volcanic source rocks, and early meteoric diagenesis).     

Vaccines for colorectal cancer: an update

Colorectal cancer (CRC) is known as the third most common and fourth leading cancer associated death worldwide. The occurrence of metastasis has remained as a critical challenge in CRC, so that distant metastasis (mostly to the liver) has been manifested in about 20%-25% of patients. Several screening approaches have introduced for detecting CRC in different stages particularly in early stages. The standard treatments for CRC are surgery, chemotherapy and radiotherapy, in alone or combination. Immunotherapy is a set of novel approaches with the aim of remodeling the immune system battle with metastatic cancer cells, such as immunomodulatory monoclonal antibodies (immune checkpoint inhibitors), adoptive cell transfer (ACT) and cancer vaccine. Cancer vaccines are designed to trigger the intense response of immune system to tumor-specific antigens. In two last decades, introduction of new cancer vaccines and designing several clinical trials with vaccine therapy, have been taken into consideration in colon cancer patients. This review will describe the treatment approaches with the special attention to vaccines applied to treat colorectal cancer.     

Selective binding of RGMc/hemojuvelin, a key protein in systemic iron metabolism, to BMP-2 and neogenin

Juvenile hemochromatosis is a severe and rapidly progressing hereditary disorder of iron overload, and it is caused primarily by defects in the gene encoding repulsive guidance molecule c/hemojuvelin (RGMc/HJV), a recently identified protein that undergoes a complicated biosynthetic pathway in muscle and liver, leading to cell membrane-linked single-chain and heterodimeric species, and two secreted single-chain isoforms. RGMc modulates expression of the hepatic iron regulatory factor, hepcidin, potentially through effects on signaling by the bone morphogenetic protein (BMP) family of soluble growth factors. To date, little is known about specific pathogenic defects in disease-causing RGMc/HJV proteins. Here we identify functional abnormalities in three juvenile hemochromatosis-linked mutants. Using a combination of approaches, we first show that BMP-2 could interact in biochemical assays with single-chain RGMc species, and also could bind to cell-associated RGMc. Two mouse RGMc amino acid substitution mutants, D165E and G313V (corresponding to human D172E and G320V), also could bind BMP-2, but less effectively than wild-type RGMc, while G92V (human G99V) could not. In contrast, the membrane-spanning protein, neogenin, a receptor for the related molecule, RGMa, preferentially bound membrane-associated heterodimeric RGMc and was able to interact on cells only with wild-type RGMc and G92V. Our results show that different isoforms of RGMc/HJV may play unique physiological roles through defined interactions with distinct signaling proteins and demonstrate that, in some disease-linked RGMc mutants, these interactions are defective.